SCHEMBL8628353

SCHEMBL8628353

CCCC(CCC)CNC=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH1B P00325 5/20 0.50
ADH1A P07327 5/20 0.50
ADH1C P00326 4/20 0.50
ADH7 P40394 4/20 0.46
ADH4 P08319 2/20 0.41
EPHX1 P07099 1/20 0.41
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA7 P43166 1/20 0.35
CA14 Q9ULX7 1/20 0.35
TSHR P16473 3/20 0.34
ALDH1A1 P00352 2/20 0.34
CYP3A4 P08684 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC8 Q9BY41 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
HDAC9 Q9UKV0 1/20 0.30
HDAC5 Q9UQL6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13950294 0.95 ADH1B (0.50) ADH1BADH1AADH1CADH7ADH4
SCHEMBL8693116 0.91 TSHR (0.46) ADH1BADH1AADH1CADH7ADH4
SCHEMBL277243 0.89 ADH1B (0.48) ADH1BADH1AADH1CADH7ADH4
SCHEMBL24013259 0.86 TSHR (0.52) ADH1BADH1AADH1CADH7ADH4
SCHEMBL9796943 0.82 ADH1B (0.56) ADH1BADH1AADH1CADH7ADH4
SCHEMBL3140921 0.82 ADH1B (0.56) ADH1BADH1AADH1CADH7ADH4
SCHEMBL20860996 0.82 ADH1B (0.43) ADH1BADH1AADH1CADH7ADH4
SCHEMBL22856952 0.81 ADH1B (0.54) ADH1BADH1AADH1CADH7ADH4
SCHEMBL271572 0.79
SCHEMBL9884573 0.79 ADH1B (0.55) ADH1BADH1AADH1CADH7ADH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0560274-B1 Antiherpes peptide derivatives having a ureido N-terminus BOEHRINGER INGELHEIM CA LTD (CA) 1998-06-24 EP claimed
EP-0560274-A1 Antiherpes peptide derivatives having a ureido N-terminus BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP claimed
EP-3810129-B1 PCSK9 ANTAGONIST BICYCLO-COMPOUNDS MERCK SHARP & DOHME LLC (US) 2023-08-16 EP disclosed
US-5830864-A RIBONUCLEOTIDE REDUCTASE INHIBITOR BOEHRINGER INGELHEIM (CANADA), LTD. (CA) 1998-11-03 US disclosed
EP-0560274-B1 Antiherpes peptide derivatives having a ureido N-terminus BOEHRINGER INGELHEIM CA LTD (CA) 1998-06-24 EP disclosed
EP-0560274-A1 Antiherpes peptide derivatives having a ureido N-terminus BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1993-09-15 EP disclosed